Jiří Ehrmann
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 7
- Cancer, Lipids, and Metabolism 7
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 8
- Cancer Cells and Metastasis 7
- Genetics top 5%
- Glioma Diagnosis and Treatment 10
- Immunology and Allergy top 5%
- Molecular Biology top 5%
- Peroxisome Proliferator-Activated Receptors 9
-
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Zdeněk KolářMarián HajdúchOndřej KalitaJan BouchalJaroslav MokrýAlice HlobílkováJosef SrovnalJozef Škarda
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (3 papers)PLoS ONE (3 papers)Journal of Neuro-Oncology (2 papers)
- Partner nations
- CzechiaUnited KingdomUnited States
In The Last Decade
Jiří Ehrmann
108 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 655
- Oncology 777
- Genetics 275
- Immunology and Allergy 140
- Molecular Biology 1.3k
Countries citing papers authored by Jiří Ehrmann
This map shows the geographic impact of Jiří Ehrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Ehrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Ehrmann more than expected).
Fields of papers citing papers by Jiří Ehrmann
This network shows the impact of papers produced by Jiří Ehrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Ehrmann. The network helps show where Jiří Ehrmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiří Ehrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 49 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 6 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 13 | |
| 6 | 2019 | 4 | |
| 7 | 2019 | 10 | |
| 8 | 2017 | 0 | |
| 9 | 2016 | 6 | |
| 10 | 2016 | 3 | |
| 11 | 2016 | 22 | |
| 12 | [Surgical therapy of pancreatic cancer - 5 years survival]. | 2015 | 2 |
| 13 | 2014 | 6 | |
| 14 | Fibrózní dysplazie lebky | 2013 | 0 |
| 15 | Enterální a parenterální výživa u pacientů s nespecifickými střevními záněty | 2011 | 1 |
| 16 | 2010 | 14 | |
| 17 | 2009 | 73 | |
| 18 | 2008 | 23 | |
| 19 | 2002 | 27 | |
| 20 | Wideband klystron high-power amplifiers for FDM/FM/FDMA applications | 1984 | 1 |
About Jiří Ehrmann
Jiří Ehrmann is a scholar working on Cancer Research, Hepatology, Oncology, Genetics and Immunology and Allergy, having authored 113 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (10 papers), Liver Disease Diagnosis and Treatment (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), MicroRNA in disease regulation (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Lipids, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (655 citations), Oncology (777 citations), Genetics (275 citations), Immunology and Allergy (140 citations) and Molecular Biology (1.3k citations). Jiří Ehrmann has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Zdeněk Kolář, Marián Hajdúch, Ondřej Kalita, Jan Bouchal, Jaroslav Mokrý, Alice Hlobílková, Josef Srovnal, Jozef Škarda, Eddie Fridman and Stanislav Filip. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, PLoS ONE, Journal of Neuro-Oncology, Diagnostic Pathology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.